Citigroup Inc Biocryst Pharmaceuticals Inc Transaction History

Citigroup Inc

$153 Billion
Q2 2024

A detailed history of Citigroup Inc transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Citigroup Inc holds 116,945 shares of BCRX stock, worth $891,120. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116,945

Previous 2,274,775 94.86%

Holding current value

$891,120

Previous $11.6 Million 93.75%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$4.13 - $6.79 $8.91 Million - $14.7 Million	-2,157,830 Reduced 94.86%	116,945 $722,000
Q1 2024 May 10, 2024	BUY	$4.89 - $7.65 $5.29 Million - $8.27 Million	1,080,811 Added 90.52%	2,274,775 $11.6 Million
Q4 2023 Feb 09, 2024	BUY	$4.98 - $6.77 $4.09 Million - $5.57 Million	822,092 Added 221.07%	1,193,964 $7.15 Million
Q3 2023 Nov 09, 2023	BUY	$6.71 - $7.92 $129,697 - $153,085	19,329 Added 5.48%	371,872 $2.63 Million
Q2 2023 Aug 10, 2023	SELL	$6.96 - $8.81 $2.14 Million - $2.7 Million	-306,924 Reduced 46.54%	352,543 $2.48 Million
Q1 2023 May 11, 2023	BUY	$7.94 - $11.84 $2.53 Million - $3.77 Million	318,249 Added 93.27%	659,467 $5.5 Million
Q4 2022 Feb 09, 2023	SELL	$10.5 - $14.2 $1.4 Million - $1.89 Million	-133,361 Reduced 28.1%	341,218 $3.92 Million
Q3 2022 Nov 10, 2022	BUY	$10.79 - $14.81 $741,175 - $1.02 Million	68,691 Added 16.92%	474,579 $5.98 Million
Q2 2022 Aug 10, 2022	BUY	$7.89 - $17.88 $2.67 Million - $6.06 Million	338,824 Added 505.22%	405,888 $4.29 Million
Q1 2022 May 12, 2022	SELL	$11.56 - $19.76 $3.72 Million - $6.36 Million	-321,814 Reduced 82.75%	67,064 $1.09 Million
Q4 2021 Feb 10, 2022	BUY	$11.18 - $15.46 $2.53 Million - $3.5 Million	226,689 Added 139.77%	388,878 $5.39 Million
Q3 2021 Nov 10, 2021	BUY	$14.21 - $17.65 $2.3 Million - $2.86 Million	162,189 New	162,189 $2.33 Million

Others Institutions Holding BCRX

# of Institutions

257

Shares Held

173M

Call Options Held

397K

Put Options Held

444K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.42B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account